Abstract
Tumors express numerous specific receptors for peptide ligands (Eckelman 1994, Reubi 1995). Thus, the development and application of peptides and proteins, including monoclonal antibodies and their fragments for receptor mapping, tumor targeting and therapy control is one of the most active areas of radiopharmaceutical research (Miller 1993, Fishman et al. 1993).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albert R., Marbach P., Bauer W., Briner U., Fricker G., Bruns C., Ness J. (1993) SDZ CO 611: A highly potent glycated analog of somatostatin with improved oral activity. Life Sci. 53, 517–525
Aloj L., Lang L., Jagoda E., Neumann R.D., and Eckelman W.C. (1996) Evaluation of human transferrin radiolabeled with N-succinimidyl 4-[fluorine-18](fluoromethyl) benzoate. J Nucl. Med. 37, 1408–1412
Amherdt M., Patel Y.C., Orci L. (1989) Binding and internalization of somatostatine, insulin and glucagon by cultured rat islet cells. J.C1in.Invest. 84 412–417
Anderson C.J., Edwards W.B., Pajeaun T.S., Zinn K.R., Welch M.J. (1994) Cu-64-TETA-D-Phe-1octreotide: A positron emitting somatostatin receptor imaging agent with receptor binding and renal clearance similar to In-111-DTPA-D-Phe-1-Octreotide. J.Nucl.Med. 35, 106p (abstr)
Angelberger P. Virgolini I. Buchheit O., Egger M., Portner R., Kvaternik H. (1995) Radiopharmaceutical development of 123I-vasoactive intestinal peptide (VIP) for receptor scintigraphy in oncology. J.Label. Compds. Radiopharm. 37, 502–503.
Awashti V., Gambhir S., Sewatkar A.B. (1993) 99mTc-Insulin: Labeling, biodistribution and Scintiimaging in Animals. Nucl.Med.Biol. 21 251–254
Babich J.W. Solomon H., Pike M.C., Kroon D., Graham W., Abrams M.J., Tompkins R.G., Rubin R.H: Fischmann A.J. (1993) Technetium-99m-Labeled Hydrazino Nictotinamide Derivatized chemotactic Peptide Analogs for Imaging Focal Sites of Baceterial Infection. J.Nucl.Med. 34 1964–1974
Babich J.W., Graham W., Barrow S.A., Fischman A.J. (1995) Comparison of the infection imaging properties of a 99mTc labeled chemotactic peptide with 111In-IgG. Nucl. Med. Biot 22, 643–648
Bakir M.A., Eccles S.A., Babich J.W., Aftab N., Styles J.M., Dean C.J., Ott R.J. (1992) c-erbB2 Protein overexpression in breast cancer as a target for PET using iodine-124-labeled monoclonal antibodies. J.Nucl.Med 33 2154–2160
Bakker W.H., Krenning E.P., Breeman W.H., Hofland L.J., Marbach P., Ness J., Pralet P., Stolz B., Koper J.W., Lamberts S.W.J., Visser T.J., Krenning E.P. (1991) [111 In-DTPA-D-phel]octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor positiv tumors: synthesis, radiolabeling and in vitro validation. Life Sci. 49 1583–1591
Bakker W.H., Krenning E.P., Breeman W.H., Koper J.W., Kooij P.P., Reubi J.C., Klijn J.G., Visser T.J., Docter R., Lamberts S.W. (1990) Receptor scintigraphy with radioiodinated somatostatine analogue: radiolabeling, purification and in-vivo application in animals. J.Nucl.Med. 31 1501–1509
Barany G. and Merrifield R.B. (1980) Solid phase peptide synthesis. In: The Peptides: Analysis, Synthesis, Biology. Vol.2.: Special methods in peptide synthesis (Part 1). Chap. 1, 185. Eds: E.Gross und J.Meienhofer. Academic Press, New York
Barrett J.A. Damphousse D.J., Heminway S.J., Liu S., Edwards D.S., Looby R.J., and Caroll T.R. (1996) Biological ecaluation of Tc-99m-labeled cyclic glycoprotein IIb/Illa receptor antagonists in the canine arteriovenous shunt and deep vein thrombosis models: Effects of chelators on biological properties of [99mTc]chelator-peptide conjugates. Bioconjugate Chem. 7, 196–202
Bayley H., and Staros J.V. (1984) Photoaffinity labeling and related techniques. In: Azides and Nitrenes. Ed.: E.F.V.Scriven. Chap. 9, 433–490. Academic Press, Orlando
Ben-Haim S., Kahn D., Weiner G.J., Madsen M.T., Waxman A.D., Williams C.M., Clarke-Pearson D.L., Coleman R.E., Maguire R.T. (1993) The Safety and Pharmacokinetics in Adult Subjects of the Intravenously Administered 99mTc-labeled 17 Amino Acid Peptide (CYT-379). Nucl.Med.Biol. 21 131–142
Benyai I., Lupattelli G., Li S.R., Pomgratz S., Yang Q., Böck P., Angelberger P., Virgolini I. (1994) Comparison of iodine-123 low density lipoprotein (LDL) and indium-111 LDL to mononuclear cells of healthy normolipaemic controls and patients with heterozygous familial hypercolesterolaemia. Eur. J. Nucl. Med. 21 634–639
Beschiaschvili G. and Seelig J. (1990) Peptides Binding to lipid bilayers. Binding isotherms and c-potential of a cyclic somatostatin analogue. Biochemistry 29 10995–11000
Beschiaschvili G. and Seelig J. (1991) Peptide binding to lipid membranes. Spectroscopic studies on the insertionof a cyclic somatostatin analog into phospholipid bilayers. Biochimica et Biophysica Acta 1061 78–84
Beschiaschvili G. and Seelig J. (1992) Peptides Binding to lipid bilayers. Nonclassical hydrophobic effect and membrane-induced pK shifts. Biochemistry 31 10044–10053
Block D., Coenen H.H., and Stöcklin G. (1988) N.c.a 18F-fluoroacylation via fluorocarboxylic acid esters. J.Label.Compds.Radiopharm. 25 185–200
Block D., Coenen H.H., Laufer P., Stöcklin G.. (1986) N.c.a [18F]-Fluoroalkylation via nucleophilic fluorination of disubstituted alkanes and application to the preparation of N-[18F]fluoroethylspiperone. J.Label.Comp.Radiopharm. 23 1042–1044
Block D., Coenen H.H., Stöcklin G. (1987) N.c.a 18F-fluoroalkylation of H-acidic compounds. J. Label. Comp.Radiopharm. 25 201–216
Bolton A.E. and Hunter W.M. (1973) The labeling of proteins to high specific radioctivities by conjugation to a 125I-containing acylation agent. Biochem.J. 133 529–539
Breeman W., Kweekeboom D.J., Kooij, P.M., Bakker W.H., Hofland L.J., Visser T.J., Ensing G.J., Lamberts S.W.J., Krenning E.P. (1995) Effect of dose and specific activity on tissue distribution of In-I11pentetreotide in rats. J.Nucl.Med. 36 623–627
Breeman W.A.P., Van Hagen M.P., Visser-Wisselaar H.E., van der Pluijm M.E., Koper J.W., Setyono-Han B. Bakker W.H., Kwekkeboom D.J., Hazenberg M.P., Lamberts S.W.J., Visser T.J., Krenning E.P. (1996) In Vitro and In Vivo Studies of Substance P Receptor Expression in Rats with the New Analog [Indium-111-DTPA-Arg’]Substance P. J.Nucl.Med. 37 108–117
Brockmann J. and Rösch F. (1995b) Labeling of small peptides with yttrium and gallium via a new DOTA-derivative of DFO using different disuccinimidyl esters as linkers. J.Label.Compds.Radiopharm. 37 516–518
Brockmann J., Rösch F., Herzog H., Stolz B., Bruns C., Stöcklin G. (1995a) Un vivo uptake kinetics and dosimetric calculations of 86Y-DTPA-octreotide with PET as a model for potential endotherapeutic octreotides labeled with 90Y. J. Lab. Compds. Radiopharm. 37, 519–521
Bruns C., Stolz B., Albert R, Marbach P. Pless J. (1993) OctreoScan 111 for imaging of a somatostatin receptor positive islet cell tumor in rat. Hormone and Metabolic Research Suppl. Ser. 27, 4–11
Bruns C., Weckbecker G., Raulf F., Kaupmann K., Schoeffter P., Hoyer D., Lübbert H. (1994) Molecular pharmacology of somatostatin receptor subtypes. Ann.N.Y.Acad.Sci. 733, 138–146
Chi D.Y., Kilbourn M.R., Katzenellenbogen J.A., and Welch M.J. (1987) A Rapid and Efficient Method for the Fluoroalkylation of Amines and Amides. Development of a Method Suitable for Incorporation of the Short-Lived Positron Emitting Radionuclide Fluorine-18. J.Org.Chem. 52, 658–664
Chowdry V., and Westheimer F.H. (1979) Photoaffinity labeling of biological systems. Ann.Rev. Biochem. 48 293–325
Clerico A., Iervasi G., Mafredi C., Salvadori S., Marastoni M., Del Chicca G.M., Giannessi D., Del Ry S., Andreassi M.G., Sabatino L., Iascone M.R., Biagini A., Donato L. (1995) Eur. J. NucLMed. 22, 997–1004
Corstens F.H.M., van der Meer J.W.M. (1991) Chemotactic peptides: New locomotion for imaging of infection. J. Nucl. Med. 31 491–494
Doering W. and Odum R.A. (1966) Ring enlargement in the photolysis of phenyl azide. Tetrahedron 22, 81–93
Downer J.B., McCarthy T.J., Edwards W.B., Anderson C.J., Welch M.J. (1995) Reactivity of radiolabeling agent p-[18F]fluorophenacyl bromide. J Label. Compds. Radiopharm. 37, 127–129
Draznin B., Sherman N., Sussman K.E., Dahl R., Vatter R. (1985) Internalization and cellular processing of somatostatin in primary cultures of rat anterior pituitary cells. Endorinology. 177, 980
Eastman R.C., Carson R.E., Shai Y., Channing M.A., Dunn B.B., Lesniak M.A., Baas E.J., Jones E.,Bacher J.D., Kirk K.L., Jackobson K.A., Herscovitch P., Roth J.(1990) Imaging of insulin receptors in vivo using 18f-Labeled insulin. J.Nucl.Med. 31 791 (abstr.)
Eckelman W.C. (1994) The application of Receptor theory to Receptor-binding and Enzyme-binding Oncologic Radiopharmaceuticals. Nucl.Med.Biol. 21 759–769
Fishman A.J., Babich J.W., Strauss H.W. (1993) A ticket to ride: Peptide Radiopharmaceuticals. J.Nucl.Med. 34 2253–2263)
Fishman A.J., Pike M.C., Kroon D., Fucello A.J., Rexinger D., Kate C., Wilkinson R., Rubin R.H., Strauss W.H. (1991) Imaging focal sites of bacterial infection in rats with In-111-labeled chemotactic peptide analogs. J. Nucl.Med. 32, 483–491
Fixmann T, Wester H.J., Krummeich C., Förmer W., Holschbach H., Harnacher K., Müller-Gärtner H.W., Stöcklin G. (1995) F-18- and I-123-labeled apamin: radiolabeling, in vitro and in vivo evaluation with mice. Eur. J. Nucl.Med. 22, 770 (abstr)
Fraser C.M. (1995) Structure and functional analysis of G-protein coupled receptors and potential diagnostic ligands J.Nucl.Med. 36 17s-21s
Fricker G., Dubost V., Schwab D., Bruns C., Thile C. (1994) Heterogenity in hepatic transport of somatostatin analog octapeptides. Hepatology 20 191–200
Garg P.K, Archer G.E., Bigner D.D., Zalutsky M.R. (1989a) Synthesis of radiolabeled N-succinimidyl iodobenzoate: Optimization for use in antibody labeling. Appl.Radiat.Isot. 40 485–490
Garg P.K., Garg S., Zalutsky M.R.. (1991) Fluorine-18 Labeling of Monoclonal Antibodies and Fragments with Preservation of Immunoreactivity. Bioconjugate Chem. 2, 44–49
Garg P.K., Slade S.K., Harrison C.L., Zalutsky M. (1989b) Labeling proteins using aryl iodide acylating agents: Influence of meta vs para substitution on in vivo stability. Nucl.Med.Biol. 16 727–733
Gauldie J., Hanson J.M., Rumlanek F.D., Shipolini R., Vernon C.A. (1976) The peptide components of bee venom. Eur.J.Biochem. 61 369–376
Gehlert D.R. and Gackenheimer S.L. (1993) Comparison of the biodistribution of binding sites for the potassium channel ligands [125I]Apamin, [125I]charybdotoxin and [125I]iodoglyburide in the rat brain. Neuroscience 52 191–205
Geiger R. (1976) Chemie des Insulins. Chemiker-Zeitung 100 111–129
Gibson E.R., Beauchamp H.T., Fioravanti C., Brenner N., Bums H.D. (1994) Receptor binding radiotracers for the angiotensin II receptor: Radioiodinated [Sar1,lle18]Angiotensin II Nucl. Med. Biol. 21 593–600
Goldenberg D.M.(1992) Cancer Imaging and therapy with radiolabeled antibodies. In Imunobiology of Proteins and Peptides, Vol 6 (Edited by E.Atassi) Plenum Press, New York
Goodwin D.A. (1987) Pharmacokinetics and antibodies. J.Nucl.Med. 28 1358–1362
Grainer C., Muller E.P., van Rietschoten J. (1978) Use of synthetic analogs for a study on the structure-activity relationship of apamin. Eur. J. Biochem. 82 193–299
Guhlke S. Wester H.J. Biersack H.J., Stöcklin G. (1994a) Simplified synthesis of n.c.a. [18F]fluoroacylation agents via 2-[18F]fluoropropionic acid chloride in view of remote controlled labeling of peptides and proteins. J.Label.Compds. Radiopharm. 35 194–196
Guhlke S., Coenen H.H. and Stöcklin G. (1994b) Fluoroacylation Agents Based on Small n.c.a.[18F]Fluorocarboxylic Acids. Appl. Radiat. Isot. 45 715–727
Guhlke S., Wester H.-J., Bruns Ch., Stöcklin G. (1994c) (2-[18F]Fluoropropionyl-(D)phel)-octreotide, a Potential Radiopharmaceutical for Quantitative Somatostatin Receptor Imaging with PET: Synthesis, Radiolabeling, In Vitro Validation and Biodistribution in Mice. Nucl. Med. Biol. 21 819–825
Habermann E. (1984) Apamin. Pharmac. Ther. 25 255–270
Hamacher K., and Hamkens W. (1995) Remote Controlled One-step Production of 18F Labeled Butyrophenone neuroleptics Exemplified by the Synthesis of n.c.a. [18F]N-Methylspiperone. Appl.Radiat.Isot. 46 911–912
Hamacher K., Blessing G., Nebeling B. (1990) Computer aided synthesis (CAS) of no-carrier-added 2[18F]fluoro-2-deoxy-D-glucose: an efficient automated system for the aminopolyether-supported nucleophilic fluorination. Appl. Radiat.Isot. 41 49–55
Hamacher K., Coenen H.H., and Stöcklin G. (1986) Efficient stereospecific synthesis of no-carrieradded 2-[18F]fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J.Nucl.Med. 27 235–238
Harris T.D., Barret J.A., Bourque J.P., Caroll T.R., Damphousse P.R., Edwards D.S., Glowacka D., Liu S., Looby R.J., Poirier M.J., Rajopadhye M, and Yu. K. (1994) Design and synthesis of radiolabeled GPIIb/Illa receptor antagonists as potential thrombus imaging agents. J.Nucl.Med. 35 245 (abstract)
Hassan M., Refai E., Andersson M., Schnell P.O., Jacobsson H. (1994) In Vivo Dynamical Distribution of 131I-VIP in the Rat Studied by Gamma-cammera. Nucl.Med.Biol. 21 865–872
Haubner R., Gratias R., Goodman S.L., Kessler H. (1996) RGD plus X: Structure/ Activity investigations on cyclic RGD-peptides. In: Peptides: Chemistry, Structure and Biology, Kaumaya P.T.P. and Hodges R.S. (eds.) Mayflower Scientific Ltd
Haubner R., Gratias R., Diefenbach B., Goodman S.L., Jonczyk A. and Kessler H. (1996) Structural and functional aspects of RGD containing cyclic pentapeptides as highly potent and selective integrin avß3 antagonists. J.Am. Chem.Soc. 118 7461–7472
Haubner R., Schmitt W., Hölzemann G., Goodman S.L., Jonczyk A., Kessler H. (1996) Cyclic RGD peptides containing 6-turn mimetics. J.Org.Chem. 118 7881–7891
Hermann L.W., Fischmann A.J., Tompkins R.G., Hanson R.N., Boyn C., Strauss H.W., Elmaleh L.W. (1990) The use of pentafluorphenyl derivatives for 18F-labeling of proteins Nucl.Med.Bio1. 21 1005–1010
Herzog H., Rösch F, Stöcklin G., Lueders C., Quaim S.M, Feinendegen L.E (1993) Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 endoradiotherapeutics. J. Nucl. Med. 34 2222–2226
Hixson S.H. und Hixson S.S. (1975) p-Azidophenacyl bromide, a versatile photolabile bifunctional reagent. Reaction with Glyceraldehyde-3-phosphate dehydrogenase. Biochemistry. 14 4251
Hnatowitch D.J. (1990) Antibody radioplabeling, problems and promises. Nucl. Med. Biol. 17, 49–55
Hoffman T.J., Sieckamn G.L. Volkert W.A. (1995) Targeting Smal Cell Lung Cancer Using Iodinated Peptide Analogs. J.Label. Compds. Radiopharm. 37 321–323
Hugues H., Duval D., Kitabgi P., Ladzdunski M., Vincent J.P. (1982a) Preparation of a pure moniododo derivative of the bee venom neurotoxin apamin and ist binding properties to rat brain synaptosomes. J. Biol. Chem. 257 2762–2769
Hugues M., Romey G., Duval D., Vincent J.P., Lazdunski M. (1982b) Apamin as a selctive blocker of calcium-dependent potassium channels in neuroblastoma cells: Voltage-clamp and biochemical characterization of the toxin receptor. Proc.Natl.Acad.Soc. USA 79, 108–1312
Hunter M.J. and Ludwig M.L. (1962) The reaction of imidoesters with proteins and related molecules. J. Am.Chem. Soc. 84 3491–3504
Ikeda M., Dewar D., McCulloch J. (1991) Selective reduction of [1251]apamin binding sites in alzheimer hippocampus: a quantitative autoradiographic study. Brain Research 567 51–56
Imman K. (1981) Peptide synthesis with minimal protection of side-chain functions.In: The Peptides: analysis, Synthesis, Biology. Vol.3.: Protection of functional groups in peptide synthesis. Chap. 6, 254–293. Eds: E.Gross and J.Meienhofer. Academic Press, New York
Jacobson K.A., Furlano D.C., Kirk K.L. (1988) A prosthetic group for the rapid introduction into peptides and functionalized drugs. J. Fluorine Chem. 39 339–347
Jong de M., Bakker W.H., Breeeman W.A.P, van der Pluijm M.E., Kooij P.P.M., Visser T.J., Docter, R.Kreening E.P. (1993. Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPAD-Phe 1 -octreotide by isolated perfused rat liver. J.Nucl.Med. 34 2025–2030
Kaupmann K., Bruns C., Raulf F., Weber H.P., Mattes H., Lübbert H. (1995) Two amino acids, located in the transmembrane domain VI and VII, determine the selectivity of the peptide agonist SMS 201–995 for the SSTR2 somatostatin receptor. The EMBO Journal, 14 727–735
Kilboum M.R., Dence C.S., Welch M.J., Mathias C.J. (1987) Fluorine-18 Labeling of Proteins. J. Nucl.Med. 28 462–470
Knight L.C., Lister-James J. Dean R.T., Maurer A.-H. (1993) Evaluation of Tc-99m Labeled Ccylic Peptides for Thrombus Imaging. JNucl Med 14 17p (abstr)
Knight L.C., Radcliffe R., Maurer A.H., Rodwell J.D., Alvarez V.L. (1994) Thrombus imaging with technetium -99m synthetic peptides based upon the binding domain of a monocloanal antibody to activated platelets. J.Nucl.Med. 35 282–288
Kragh-Hansen U. (1981) Molecular aspects of igand binding to serum albumin. Am. Soc. Pharm. Exper.Therap. 33 17–53
Krummeich C., Holschbach M., Stöcklin G. (1995) Convenient high yield direct electrophilic n.c.a. radioiodination of poorly activated anisole derivatives using the Iodo-genTM trifluoroacetic acid system. J.Label.Compd. Radiopharm. 37 628–630
Krummeich C., Holschbach M., Stöcklin G. (1996) Convenient direct N.c.a. electrophilic radioiodination or arenes using iodo-gen. Appl. Radial. Isot. 47 489–495
Kurtaran A., Leimer M, Kasere K, Yang Q., Angelberger P., Niederle B., Virgolini I. (1996) Combined use of 111In-DTPA-D-Phe-l-Octreotide (OCT) and 123I-Vasoactive Intestinal Peptide in the Loacalization Diagnosis of Medullary Thyroid Carcinoma (MTC). Nucl. Med. Biol. 23 503–507
Kurtaran A., Li S.R., Raderer M, Leimer M., Müller C., Pidlich J., Neuhold N., Hübsch P., Angelberger P., Scheidhauer W., Virgolini I. (1995) Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123I-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas. J.Nucl.Med. 36 1875–1881
Kutz K., Nüesch E., Rosenthaler L. (1986) Pharmacokinetics of SMS 201–995 in healthy subjects. Scand. J. Gastroenterol. 21 65–72
Kwawli L.A. and Kassis A.I. (1989) Synthesis of 1251-labeled N-succinimidyl p-iodobenzoate for use in radiolabeling antibodies. Nucl.Med.Biol. 16 727–733
Lambert R., Willenbrock R., Tremblay J., Bavaria G., Langlois Y., Hpgan K., Tartaglia D., Flanagan R.J., Hamet P. (1994) Receptor imaging with atrial natriuretic peptide Part 1: High specific activity iodine123-atrial natriuretic peptide. J.Nucl.Med. 35 628–637
Lamberts S.W.J., Krenning E.P., Reubi J.C. (1991) The role of somatostatin and its analogues in the diagnosis and treatment of tumors. Endocrine Reviews. 12 450–482
Lanathan M.V., Bass L.A., Welch M.J., Anderson C.J. (1995) Metabolism of octreotide conjugates of 64Cu-TETA, 64Cu-CPTA and 111In-DTPA. J. Label. Compds. Radiopharm 37 510–512
Lang G., Choi C.W., Lee T.J., Webber K.O. Yoo T.M., Chang N., Le N., Jagoda E., Paik C.H., Pastan I. Carrasquillo J.A., Eckelman W.C. (1995b) Identification of metabolites of F-18 labeled TAC disulfide stabilized monoclonal antibody variable-region fragments in mice. J. Label. Compds. Radiopharm. 37 551–553
Lang G., Eckelman W.C. (1995a) Improved one-step synthesis of N-succinimidyl 4-[18F]fluoromethylbenzoate for protein labeling. J. Label. Compds. Radiopharm. 37 551–553
Lang L., Eckelmann W.C. (1994) One-Step Synthesis of 18F labeled [18F]-N-succinimidyl 4-(fluoromethyl) benzoate for Protein Labeling. Appl. Radial. Isot. 45 1155–1163
Langen K.J. Coenen H.H. Roosen N., Kling P., Muzik O., Herzog H., Kuwert T., Stöcklin G., Feinendegen L.E. (1990) SPECT studies with L-3[I-123]iodo-alpha-methyltyrosine: Comparison with PET [I124]IMT and first clinical results. J.Nucl.Med. 31 281–286
Larson S.M. (1994) Cancer or Inflammation? The holy Grail for Nuclear Medicine. J.Nucl.Med. 35 1653–1655
Lathe R. (1985) Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations. J.Mol.Biol. 183 1–12
Leitha T., Staudenherz A., Gmeiner B., Hermann M., Hüttinger M., Dudczak R. (1993) Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy. Eur.J. Nucl. Med. 20 674–679
Lemaire M., Azira M., Dannecker R, Marbach P., Schweitzer A., Maurer G. (1989) Disposition of sandostatin, a new synthetic somatostatin analogue in rats. Drug Metabol. and Dispos. 17 699–703
Lister-James J., Knight L.C., Maurer A.H., Bush L.R., Moyer B.R., Dean R.T. (1996) Imaging with Tc-99m-Labeled Activated Platelet Receptor Binding Peptide. J.Nucl.Med 37 775–781
Liu S., Edwards D.S., Looby R.J., Poirier M.J., Rajopadhye M, Bourque J.P., and Caroll T.R. (1996) Labeling cyclic glycoprotein IIb/Illa receptor antagonists with Tc-99m by the preformed chelate approach: Effects of chelators on properties of [99mTc]chelator-peptide conjugates. Bioconjugate Chem. 7 196–202
Locher M., Johnston J., Müller T., Borbe H.O., Kutscher B., Engel J. (1994) Synthesis of [U-14C]Arg labelled decapeptide cetrorelix, a novel lutenizing hormone-releasing hormone antagonist. J. Lab. Compds. Radiopharm. 34, 1091–1098
MacGillivary R.T.A, Mendez E., Shewale J.G., Shina S.K., Lineback-Zins J., Brew K. (1983) The primary structure of human serum transferrin. J.Biol.Chem. 258 3543–3553
Maina T., Stolz B. Albert R., Bruns C., Koch P., Macke H. (1994) Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219–387) labelled with technetium-99m. Eur. J. Nucl. Med. 21 437–444
Martinez J., Tolle J.C., Bodanszky M. (1979) Side reactions in peptide chemistry. Int.lPeptide Protein Res. 13 22–27
Meyer G.J., Coenen H.H., Waters S., Långström B., Cantineau R., Strijckmans K., Vaalburg W., Halldin C., Crouzel C., Mazière B. Luxen A. (1993) Quality assurance and quality control of short lived radiopharmaceuticals for PET. In: Radiopharmaceuticals for Positron Emission Tomography, Methodological aspects. Eds.: G.Stöcklin and V.W.Pike. Developments in Nuclear Medicine, Vol.24, Kap.3, 91–150, Kluwer Academic Publishers
Miller L. (1993) Synthetic peptides come of age. J. Nucl. Med. 34 15N–30N
Moerlein S.M. (1990) Regiospecific aromatic radioiodination via no-carrier-added copper(I)-assisted iododebromination. Radiochemica Acta 50 55–61
Morel G. (1994) Internalization and nuclear localization of peptide hormones. Biochemical Pharmacology. 47, 63–76
Morel G., Pelletier G., Heisler S. (1986) Internalization and subcellular distribution of radiolabelled somatostatin-28 in mouse anterior pituitary tumor cells. Endocrinology 119 1972–1979
Müller-Platz C.M., Kloster G., Legler G., and Stöcklin G. (1982) 18F-Fluoroacetate: An Agent for Introducing No-Carrier-Added Fluorine-18 into Urokinase without loss of Biological Activity. JLabel Compds Radiopharm. 19 1645
Murray J.L. Mujoo K., Williams C., Mansfield P., Wilbur D.S., Rosenblum M.G. (1991) Variables influencing tumor uptake of anti-melanoma monoclonal antibodies radioiodinated using paraiodobenzoyl (PIP)conjugate. J.Nucl.Med. 32 279–287
Muto P., Lastoria S., Varrella P., Vergara E., Salvatore M., Morgano G., Lister-James J., Bernardy J.D., Dean R.T., Wencker D., Borer J. (1995) Detecting deep venous thrombosis with Tc-99m-labeled synthetic peptide P280. J.Nucl.Med. 36 1384–1391
Nagren K, Ragnarsson U., and Langström B. (1986) The synthesis of the neuropeptide Met-Enkephaline and the two metabolic fragments labeled with 11C in the methionine group. Appl. Radiat.Isot. 37 537–539.
Ott R.J., Tait D. Fowler M.A., Babich J.W. (1992) Br.J.Radiol. 65 787
Page R.L., Garg P.K., Garg S., Archer G.E., Bruland Ø.S., Zalutsky M.R. (1994a) PET Imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment. J. Nucl.Med. 35, 1506–1513
Page R.L., Garg P.K., Garg S., Archer G.E., Brunland O.S., Zalutsky M.R. (1994) PET imaging of osteosarcoma in dogs using fluorine-18 labeled monoclonal antibody Fab fragment. J Nucl Med. 34 533
Pandey R.N., Wilson J.D., Zhao X.G., and Schlom J. (1991) Photolabeling: A new approach for radioiodination. Antibody, Immunoconj. and Radiopharm. 4, 399–407
Pandurangi R.S., Kuntz R.R., Volkert W.A. (1995a) Photoaffinity labeling of B72.3 antibodies using C-14methyltetrafluoro azido benzoate. J.Nucl.Med. 36 156p abstr.
Pandurangi R.S., Kuntz R.R., Volkert W.A. (1995b) Photolabeling of human serum albumin by 4-Azido-2- ([14C]-methylamino)trifluorobenzonitrile. A high efficiency, long wavelength photolabel. Appl. Radial. Isot. 46, 233–239
Pandurangi R.S., Kuntz R.R., Volkert W.A. (in press) High efficiency photolabeling of human serum albumin and y-globulin with 4-azido-2,3,5,6-tetrafluoro-14C-methyl benzoate. Bioconjugate Chem.
Paul R. (1962) 0-Acylation of tyrosine during peptides synthesis. J.Org. Chem. 28 236
Pentlow K.S., Lambrecht R.M. Cheung N.K.V., Larson S.M. (1991) Med. Phys. 18, 357 (1991)
Pless J., Bauer W., Briner U., Doepfner W., Marbach P., Maurer R., Petcher T., Reubi J.C. and Vanderscher J. (1986) Chemistry and pharmacology of SMS 201–995, a long acting octapeptide analogue of somatostatin. Int.Congr. Ser.-Excerpta Med. 683, 319
Ramachandran J. and Li C.H. (1963) The synthesis of L-valyl-L-lysyl-L-valyl-L-tyrosyl-L-proline. J.Org.Chem. 28, 173–177
Raulf R., Perez J., Hoyer D., Bruns C. Differential expression of five somatostatin receptor subtypes, SSTR1–5, in the CNS and peripheral tissue. (1994) Digestion. 55 (suppl.3), 46–53.
Reubi J.C. (1995) In vitro Identification of Vasoactive Intestinal Peptide Receptors in Human Tumors: Implications for Tumor Imaging. J.Nucl.Med. 36 1846–1853
Reubi J.C. (1995) Neuropeptide Receptors in Health and Disease: The Molecular Basis for In Vivo Imaging. J.Nucl.Med. 36 1825–1835
Reynor K., Reisine T.(1992) Somatostatin Receptors. Critical. Rev. Neurobiol. 6 273–289
Romey G., Hugues M., Schmid-Antomarchi H., Lazdunski M. (1984) Apamin: a specific toxin to study a class of Ca2+ - dependend K+ channels. J. Physiol. 79, 259–264
Rösch F., Herzog H., Plag C., Neumaier B., Braun U., Müller-Gärtner H.W., Stöcklin G. (1996) Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography. Eur.J.Nucl.Med. 23 958–966
Ruoho A.E., Kiefer H., Roeder P.E., Singer S.J.. The mechanism of photoaffinity labeling. Proc.Nat.Acad.Sci.USA. 70, 2567–2571 (1973)
Sagnella G.A. and MacGregor G.A. (1984) Cardiac peptides and the control of sodium excretion. Nature 309 666–667
Savarese T.M. Fraser C.M. (1992) In vitro mutagenesis and the search for structure-function relationship among G-protein coupled receptors. Biochem J. 283 1–19
Schiffinann E., Corcoran B.A. and Wahl S.M. (1975) N-Formylmethioyl Peptides as Chemoattractants for Leucocytes. Proc. Nat. Acad. Sci. USA 72 1059–1062
Seelig J., Nebel S., Ganz P., Bruns C. (1993) Electrostatic and nonpolar peptide-membrane interactins. Lipid binding and functional properties of somatostatin analogues of charge z = +1 to z = +3. Biochemistry 32 9714–9721
Serafini A.N.. (1993) From monoclonal antibodies to peptides and molecular recognition units: An overview. J.Nucl.Med. 34 533–536
Shai Y., Kirk K.L., Channing M.A., Dunn B.B., Lesniak M.A., Eastman R.C., Finn R.D., Roth J., and Jacobson K.A. (1989) 18F-Labeled Insulin: A Prosthetic Group Methodology for Incorporation of a Positron Emitter into Peptides and Proteins. Biochemistry 28 4801–4806
Shattil S.J., Hoxie J.A., Cunningham M., Brass L.F., (1985) Changes in the platelet membrane glycoprotein IIb, IIIa complex during platelet activation. J.Biol.Chem. 260 11107–11114
Shiue C.Y., Wolf A.P., Hainfeld J.F. (1988) Synthesis of 18F-labeled N-(p-[18F]fluorophenyl]maleimide and its derivative for labeling monoclonal antibodies with 18F. J.Label. Compds. Radiopharm. 26 278
Smith B.D., Nakanishi K., Watanabe K., Ito S. (1990) 4-Azido[3,5-3H]phenacyl bromide, a versatile bifunctional reagent for photoaffinity radiolabeling. Synthesis of prostaglandin 4-azido [3,5-3H]phenacyl-esters. Bioconjugate Chem. 1 363–364
Smith-Jones P.M., Stolz B., Bruns C., Albert R., Reist H.W., Friedrich R., Mäcke H.R (1994). Gallium-67/Gallium-68-DFO-octreotide - A potential radiopharmaceutical for PET imaging of somatostatin receptor-postive tumors: Synthesis and radiolabeling, in-vitro and preliminary in-vivo studies. J. Nucl. Med. 35 317–325
Stöcklin G. (1991) Radioligands for PET studies of D2-receptors: Butyrophenone and ergot derivatives. In: Brain dopaminergic systems: Imaging with positron emission tomography (J.C.Baron et al. Editors), Kluwer Academic Publishers.
Stolz B., Albert R. and Bruns C. (1995) LHRH Rezeptor targeting mit [111In] markiertem DTPALHRH Analog (SDZ 218–041) - Präklinische Charakterisierung -
Stolz B., Maim T., Albert R., Briner U., Nock B., Fridrich R., Mäcke H., Bruns C. (1994) Somatostatin Rezeptor Szintigraphie mit [99mTc]N4(D)Phe 1 -Octreotid (SDZ 220–778): Präklinische Charakterisierung. Dt. Gesellschaft für Nuklearmedizin, 32. Int. Jahrestagung, 27–30 April 1994, Kiel; Nucl. Med. 33:A27 (abstr.)
Turton D.R., Brady F., Pike V.W., Selwyn A.P., Shea M.J., Wilson R.A., DeLandsheere C.M. (1984) preparation of human serum [Methyl-11C]methylalbumin microspheres and human serum [Methyl[11C]methylalbumin for clinical use. J. Appl. Radial. Isot. 35,337–344
v.Iddon B., Meth-Cohn O., Scriven E.F.V., Suschitzky H., Gallagher P.T. (1979) Entwicklungen in der Arylnitren-Chemie: Synthesen und Mechanismen. Angew.Chem. 91, 965–981
Vaidyanathan G. and Zalutsky M.R. (1995) Fluorine-18 labeled chemotactic peptide: A potential approach for the PET imaging of bacterial infection. Nucl.Med.Biol. 22, 759–764
Vaidyanathan G., Affleck D.A., Welsh P., Zalutsky M.R. (1994a) Fluorine-18 labeled chemotactic peptide: A otential agent for the imaging of focal infection. J.Label.Compds. Radiopharm. 35£¬ 365–367
Vaidyanathan G., and Zalutsky M.R. (1994b) Improved synthesis of N-succinimidyl 4- [18F]fluorobenzoate and its application to the labeling of a monoclanal antibody fragment. Bioconjugate Chem. 5,352–356 122.
Vaidyanathan G., Bigner D.D., Zalutsky M.R. (1992a) Fluorine-18-Labeled Monoclonal Antibody Fragments: A Potential Approach for Combining Radioimmunoscintigraphy and Positron Emission Tomography. J.Nucl.Med. 33, 1535–1541
Vaidyanathan G., Zalutsky M.R. (1992b) Labeling Proteins with Fluorine-18 using N-Succinimidyl 4[18F]Fluorobenzoate. Nucl. Med. Biol. 19 275–281
Van der Laken C.J., Boerman O.C., Oyen W.J.C., van der Ven M.T.P., Claessens R.A.M.J., van der Meer J.W.M., Corstens F.H.M. (1995) Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model. Eur.J. Nucl. Med. 22 1249–1255
Vincent J.P., Schweitz H., Lazdunski M. (1975) Structure - function relationship and site of action of apamin, a neurotoxic polypeptide of the bee venom with an action on the central nervous system Biochemistry 14 2521–2525
Virgolini I., Kurtaran A., Raderer M., Leimer M., Angelberger P., Havlik E., Li. S., Scheithauer W., Niederle B., Valent P. and Eichler H.G. (1995) Vasoactive intestinal peptide-receptor scintigraphy J. Nucl. Med. 36, 1732–173
Virgolini I., Raderer M., Kurtaran A., Angelberger P., Banyi S., Yang Q., Li. S., Banyai M., Pidlich J., Niederle B., Scheithauer W., Valent P. (1994) Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N.Engl. J. Med. 331 1116–1121
Welch J.M. and Kilboum M.R. (1988) Potential labeling of monoclonal antibodies with positron emitters. In: Radiolabeled Monoclonal Antibodies for Imaging and Therapy (Srivastava S.C. Ed.) p.261. Plenum Press New York
Wester H.J. (1996a) Zur praktisch tragerfreien F-18 Fluorierung von Proteinen., Peptiden und Tyrosin. Berichte des Forschungszentrums Jülich, Jül- 3206, Forschungszentrum Jülich GmbH, Jülich, Germany
Wester H.J. Harnacher K., Stöcklin G. (1996b) A comparative study of n.c.a. fluorine-18 labeling of proteins via acylation and photochemical conjugation. Nucl.Med.Biol. 23 354–372
Wester H.J., Brockmann J., Rösch F., Stolz B., Wutz W., Herzog H., Smith-Jones P.M., Bruns C., Stöcklin G. (1995a) Quantitative in-vivo uptake kinetics of 18F-octreotide in tumor bearing rats as measured by PET: A comparison with 86Y-DTPA-octreotide and 68Ga-DFO-octreotide. J.Nucl.Med. 36, 1I3p-114p
Wester H.J., Brockmann J., Rösch F., Wutz W., Herzog H., Schmith-Jones P., Stolz Barabara, Bruns C., and Stöcklin G. (in press) PET-pharmaconkinetics of 18F-octreotide: A comparison with 67Ga-DFO- and 86Y-DTPA-octreotide. NuclMed.Biol.
Wester H.J., Guhlke S., Stöcklin G. (1994a) Comparative evaluation of n.c.a. 18F-fluorination agents for peptides and proteins. Eur.J.Nucl.Med. 21, 794 abstr.
Wester H.J., Guhlke S., Stöcklin G. (1994b) Regioselective [18F]fluoropropionylation of peptides and proteins in aqueous solution. J.Label.Compds.Radiopharm. 35, 297–299
Wester H.J., Hamacher K., Stöcklin G. (1994c) Simple and fast 18F-labeling of proteins by coupling with photogenerated [18F]arylnitrene. J.Nucl.Med. 35, 73p abstr.
Wester H.J., Krummeich C., Fixmann A., Former W., Müller-Gärtner H.W., Stöcklin G. (1995b) 18F- and 131I-Labeling of the octadecapeptide Apamin: A selective blocker of the Ca2+ dependent K+ channels. Synthesis and in vivo evaluation in NMRI mice. J.Label.Compds.Radiopharm. 37, 513–515
Westerberg G., and Langström B. (1994) Labeling of proteins with 11C in high specific radioactivity: [11C]albumin and [11C]transferrin. Appl.Radiat.Isot. 45, 773–782
Wilbur D.S. (1992) Radiohalogenation of proteins: An overview of radionuclides. Labeling methods and reagents for conjugate labeling. Bioconjugate Chem. 3, 433
Wilbur D.S. Hadley S.W., Hylarides M.D., Abrams P.G., Beaumier P.A., Morgan A.C., Reno J.M., Fritzberg A.R. (1989) Development of a stable radioiodinating reagent to label monoclonal antibodies for therapy of cancer. J.Nucl.Med. 30, 216–226
Williams L.T., Snyderman R., Pike M.C., Lefkowitz R.J. (1977) Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc. Natl. Acad.Sci. USA 74, 1204–1208
Wofsy L. and Singer S.J. (1963) Effect of the amidination reaction on antibody activity and on the physical properties of some proteins. Biochemistry 2, 104–116
Yamashiro D., Li C.H. (1972) Int.J.Peptide Protein Res. 4, 181–185
Zalutsky M.R., Garg P.K., Johnson S.H., Utsunomiya H., Colemann R.E. (1992) Fluorine-18-Antimyosin monoclonal antibody fragments: Preliminary investigations in a canine myocardial infarct model.J.Nucl. Med. 33, 575–580
Zweit J., Luthra S.K., Brady F., Carnochan P., Ott R.T., Jones T. (1995) Iodine-120, a new positron emitting radionuclide for PET radiopharmaceuticals. J.Label.Compds. Radiopharm. 37, 823–82
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Stöcklin, G., Wester, H.J. (1998). Strategies for Radioligand Development. In: Gulyás, B., Müller-Gärtner, H.W. (eds) Positron Emission Tomography: A Critical Assessment of Recent Trends. NATO ASI Series, vol 51. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4996-9_6
Download citation
DOI: https://doi.org/10.1007/978-94-011-4996-9_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6097-4
Online ISBN: 978-94-011-4996-9
eBook Packages: Springer Book Archive